NH Special Purpose Acquisition 17 Co. Ltd.
359090StockKQ
550.00 ▲ +7.63%
04 juin 2026
3
NH Special Purpose Acquisition 17 Co. Ltd.
550.00 ▲ +7.63%
04 juin 2026
359090StockKQ

01 / À propos

C&R Research Inc. engages in the of clinical development for pharmaceuticals and medical devices. The company's therapeutic area comprises oncology, cardiovascular, endocrinology, dermatology, central nervous system, ophthalmology, and rare disease.The company was founded in 1997 and is based in Seoul, South Korea.

Arberion
Loading market data